Aterian Announces Third Quarter 2022 Net Revenue Range; Resumes M&A Strategy

NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced that it is resuming its M&A strategy after its previously announced pause following the disruption of the global ecosystem due to the COVID-19 pandemic. The Company intends to purchase the assets of a brand in the health and wellness category. The Company believes that the acquisition will be accretive; expanding and securing market share in an existing portfolio brand’s category. The specific terms of the acquisition will not be disclosed.